Stocks Health care PBH
NYSE · Health carePrestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare Inc. brought in $1.1B of revenue over the twelve months to June 30, 2026, down 1.4% from a year earlier. Net income was $172M, a net margin of 15.6%. Operating cash flow minus capital spending left $246.4M of free cash flow in fiscal 2026. At June 30, 2026 it held $89.1M in cash against $2B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Prestige Consumer Healthcare Inc. does
Prestige Consumer Healthcare Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker PBH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $1.1B | $190.3M | $3.91 | $246.4M |
| 2025 | $1.1B | $214.6M | $4.29 | $243.3M |
| 2024 | $1.1B | $209.3M | $4.17 | $239.4M |
| 2023 | $1.1B | -$82.3M | -$1.65 | $221.9M |
| 2022 | $1.1B | $205.4M | $4.04 | $250.3M |
| 2021 | $943.4M | $164.7M | $3.25 | $213.4M |
Latest SEC filings
What Prestige Consumer Healthcare Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- July 15, 2026
- July 9, 2026Exhibits 8-K/A
- July 7, 2026Passive stake changed SCHEDULE 13G/A
- July 6, 2026
- June 30, 2026Exhibits 8-K/A
- June 29, 2026
- June 29, 2026Proxy statement DEF 14A
Questions about PBH
What does Prestige Consumer Healthcare Inc. do?
Prestige Consumer Healthcare Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker PBH.
Is Prestige Consumer Healthcare Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $172M on revenue of $1.1B, a net margin of 15.6%.
How much revenue does Prestige Consumer Healthcare Inc. make?
Over the twelve months to June 30, 2026 Prestige Consumer Healthcare Inc. reported revenue of $1.1B. That is 1.4% less than a year earlier.
When did Prestige Consumer Healthcare Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from August 14, 2026.
Similar companies
Follow PBH
Get an email when Prestige Consumer Healthcare Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PBH: get an email when it filesWhere the numbers come from
Financial figures are the values Prestige Consumer Healthcare Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.